Event Brief
Dec 7, 2025 at 4:02 AM ET
Regeneron therapy shows promise in blood cancer treatment
By The BriefBrief
A new Regeneron therapy cleared B-cell counts in aggressive blood cancer patients after the first dose.
WHO: Regeneron Pharmaceuticals
WHAT: Experimental therapy for aggressive blood cancer
WHEN: Dec 6, 2025 at 7:00 PM ET
WHERE: American Society of Hematology Annual Meeting
WHY: To present findings on the effectiveness of a new treatment
How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.
Page 21462 of 21461
Same format. Every time.
Continue reading — sign in or create a free account with
